Consistent with our results, the knockdown of RhoGDI2 expression significantly increases the phosphorylation levels of p38 kinase, and pretreatment with p38 kinase inhibitor significantly inhibits the apoptosis of RhoGDI2-depleted breast cancer cells [15]. This evidence concerns the gene ARHGDIB and breast cancer.